Journal
CANCER SCIENCE
Volume 111, Issue 8, Pages 2708-2717Publisher
WILEY
DOI: 10.1111/cas.14537
Keywords
cancer progression; cancer-associated fibroblast; heterogeneity; single-cell RNA-sequencing; tumor microenvironment
Categories
Funding
- Swedish Cancer Society
- Swedish Research Council
- Biltema Foundation
- Cancera Foundation
- Region Skane ALF funding
- Sjoberg Foundation
- Wenner-Gren Foundation
Ask authors/readers for more resources
Despite marked development in cancer therapies during recent decades, the prognosis for advanced cancer remains poor. The conventional tumor-cell-centric view of cancer can only explain part of cancer progression, and thus a thorough understanding of the tumor microenvironment (TME) is crucial. Among cells within the TME, cancer-associated fibroblasts (CAFs) are attracting attention as a target for cancer therapy. However, CAFs present a heterogeneous population of cells and more detailed classification of CAFs and investigation of functions of each subset is needed to develop novel CAF-targeted therapies. In this context, application of newly developed approaches to single-cell analysis has already made an impact on our understanding of the heterogeneity of CAFs. Here, we review the recent literature on CAF heterogeneity and function, and discuss the possibility of novel therapies targeting CAF subsets.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available